AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 163 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $67,074,010 | -11.8% | 2,710,061 | +0.9% | 1.80% | -0.7% |
Q2 2023 | $76,072,249 | +24.4% | 2,686,167 | +0.9% | 1.81% | +24.1% |
Q1 2023 | $61,137,067 | -27.3% | 2,661,605 | -11.2% | 1.46% | -28.0% |
Q4 2022 | $84,144,303 | -2.7% | 2,996,592 | -2.0% | 2.02% | -9.4% |
Q3 2022 | $86,477,000 | +33.2% | 3,057,869 | +4.4% | 2.23% | +18.3% |
Q2 2022 | $64,924,000 | -16.3% | 2,928,458 | +9.9% | 1.89% | -3.3% |
Q1 2022 | $77,586,000 | -10.8% | 2,665,275 | +0.7% | 1.95% | -2.8% |
Q4 2021 | $86,995,000 | -26.3% | 2,646,625 | +3.5% | 2.01% | -19.0% |
Q3 2021 | $117,968,000 | -16.8% | 2,556,179 | -0.7% | 2.48% | -11.6% |
Q2 2021 | $141,870,000 | +8.0% | 2,574,308 | +1.2% | 2.80% | -2.2% |
Q1 2021 | $131,352,000 | +20.1% | 2,543,600 | +0.8% | 2.87% | +23.6% |
Q4 2020 | $109,344,000 | +97.5% | 2,523,521 | +59.6% | 2.32% | +65.1% |
Q3 2020 | $55,353,000 | -12.3% | 1,581,509 | +34.1% | 1.40% | -18.9% |
Q2 2020 | $63,091,000 | +68.5% | 1,179,720 | +11.8% | 1.73% | +11.8% |
Q1 2020 | $37,449,000 | +22.3% | 1,055,500 | +64.5% | 1.55% | +59.9% |
Q4 2019 | $30,632,000 | +168.2% | 641,500 | +82.0% | 0.97% | +112.7% |
Q3 2019 | $11,421,000 | +34.3% | 352,500 | +106.7% | 0.46% | +47.7% |
Q2 2019 | $8,505,000 | +7.3% | 170,500 | +45.1% | 0.31% | +0.7% |
Q1 2019 | $7,924,000 | – | 117,500 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |